Modifications in cell culture, bioreactors, or other processing conditions can cause changes in glycosylation and affect a drug’s efficacy and safety. An understanding of the factors that can influence a drug through various stages of product development and manufacturing, as well as analytical steps to detect changes, can reduce risk and improve product quality.

In this webcast, experts will provide an overview of factors that affect cell line quality from process development through production, including regulatory considerations, factors for optimized bioreactor performance, and glycan analysis methods.